Propranolol Tablets (VA-24-00049891)   3

Background
The solicitation is issued by the Department of Veterans Affairs (VA) and the Department of Defense (DoD) for the acquisition of pharmaceutical products through their respective Pharmaceutical Prime Vendor (PPV) Programs. The purpose is to establish a supply source for drugs listed in the schedule for purchase through the PPV Programs, ensuring availability, consistency, and obtaining volume-based, committed-use pricing.

Work Details
The contract requires the supply of Propranolol HCL tablets in various strengths and quantities. Offerors must submit prices for the base year and all four one-year options for all line items. Prices offered should not exceed two decimal places and must include a 0.5% Cost Recovery Fee. Offerors must list an 11-digit National Drug Code (NDC) number for each offered drug that is unique to the offeror's company. The solicitation also includes details on the Contract Effective Date, Implementation Period, and Ordering Period.

Period of Performance
The contract will be effective from 3-14-2024 with an Implementation Period ending on August 10, 2024, and an Ordering Period in effect for one year.

Place of Performance
The products are to be delivered to various facilities including all VA facilities, all DoD Pharmaceutical Prime Vendor Program participants, Indian Health Service facilities, Bureau of Prisons facilities, Captain James A. Lovell Federal Health Care Center, and Option 2 State Veteran Homes.